Clinical Trial

Identify a Specific Immune Profile in Patients With Chronic Pelvic Pain Resistant to First-line Treatments by Measuring Th1, Th2, Th17, and Treg Cytokines Produced After Non-specific Functional Cell Stimulation - ImmunoCPP

Study acronym: ImmunoCPP
Recruiting
View on ClinicalTrials.gov →
Summary
Chronic pelvic pain (CPP) affects more than one in four women. An immune imbalance in the Th1/Th2 balance has been reported in multiple CPP situations, particularly in patients with endometriosis, but with mixed results. The use of a functional immune test, already validated in previous indications and particularly in infertility, could simulate an immune stimulation similar to that of painful attacks.
Protocol Amendment History 1 change
critical Recruitment opened 2026-07-28
Trial Details
NCT Number NCT07429773
Lead Sponsor Centre Hospitalier Universitaire de Nice
Conditions Endometriosis, Chronic Pelvic Pain Syndrome
Enrollment 120 participants
Start Date 2026-04-14
Primary Completion 2028-04 (estimated)
Study Completion 2028-04 (estimated)
Updated on ClinicalTrials.gov 2026-07-27